ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
ARTV
48 hedge funds and large institutions have $27.9M invested in Artiva Biotherapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-5
Holders Change %
-9.43%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
9
Reduced
16
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$494K |
| 2 |
HF
HRT Financial
New York
|
+$117K |
| 3 |
Goldman Sachs
New York
|
+$115K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$78.8K |
| 5 |
Jane Street
New York
|
+$66.8K |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$2.6M |
| 2 |
BlackRock
New York
|
-$1.15M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$944K |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$435K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$380K |
